Boon Industries, Inc.

Boon Industries, Inc.

BNOW
Boon Industries, Inc.US flagOther OTC
0.02
USD
- -
- -
73.42MMarket Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
CEO
William J. Reed
Full Time Employees
2
Sector
Basic Materials
Industry
Chemicals
Address
110 Spring Hill Road Grass Valley CA United States of America 95945
Business
Boon Industries, Inc. (OTC: BNOW) operates as an innovative bioscience company developing chemical solutions for the agricultural, food and beverage, hospitality, and medical industries; its core products include DiOx+, a chlorine dioxide-based disinfectant launched for the U.S. market after over 12 years of international utilization, alongside other bioscience formulations aimed at sanitization, pathogen control, and environmental applications that prioritize health, safety, and efficacy. The company manufactures these solutions at its corporate headquarters and production facility in Grass Valley, California, with previous efforts nearing completion of an expanded production site to support growth; it previously maintained a presence in Nevada City, California. Boon Industries targets diverse sectors including agriculture for crop protection, food and beverage for processing sanitation, hospitality for surface disinfection, and medical applications, operating primarily in the United States following its CEO Justin Gonzalez's leadership in global market expansion. Recent developments encompass the U.S. commercial rollout of DiOx+ to fulfill demand for affordable, non-toxic alternatives, alongside facility enhancements in Grass Valley to bolster manufacturing capacity, reflecting strategic shifts toward domestic scaling within the last few years.

Company News

APIChat
  • Boon Industries Releases Investor Presentation

  • Boon Files Form 10 with Securities and Exchange Commission

  • Boon Positions DiOx+ as Catalyst for Revenue Growth in Crop Protection Market

  • Boon Industries Retains Integrity Media for Investor Relations and Corporate Communication

  • BOON Industries Continues to Expand Distribution of DiOx+ Into New Verticals

  • The Pandemic is a Long-Term Factor (NASDAQ: QDEL) (NYSEAMERICAN: APT) (OTC US: BNOW) (NYSE: ABT)

  • BOON Completes Phase-I of EPA Testing of DIOX+ $25M Revenue on Horizon

  • BOON to Announce Major Contract Start Date for DIOX+ $52M Revenue Stream

  • BOON Moves Forward with Distribution Contracts $52M Annual Revenue Potential

  • UPDATE -- Boon Industries Chairman Letter - $25M Projection with DiOx+ Sales Underway